• Login
View Item 
  • DASH Home
  • Faculty of Arts and Sciences
  • FAS Scholarly Articles
  • View Item
  • DASH Home
  • Faculty of Arts and Sciences
  • FAS Scholarly Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Browse

All of DASH
  • Communities & Collections
  • By Issue Date
  • Author
  • Title
  • Keyword
  • FAS Department
This Collection
  • By Issue Date
  • Author
  • Title
  • Keyword
  • FAS Department

Submitters

  • Login
  • Quick submit
  • Waiver Generator

About

  • About DASH
  • DASH Stories
  • DASH FAQs
  • Accessibility
  • COVID-related Research
  • Terms of Use
  • Privacy Policy

Statistics

  • By Schools
  • By Collections
  • By Departments
  • By Items
  • By Country
  • By Authors

Landscape of tumor-infiltrating T cell repertoire of human cancers

 
Thumbnail
View/Open
5298896.pdf (1.755Mb)
Author
Li, BoHARVARD
Li, Taiwen
Pignon, Jean-ChristopheHARVARD
Wang, Binbin
Wang, Jinzeng
Shukla, Sachet
Dou, Ruoxu
Chen, Qianming
Hodi, F. Stephen
Choueiri, Toni K.
Wu, Catherine
Hacohen, NirHARVARD
Signoretti, SabinaHARVARD
Liu, Jun S.HARVARD
Liu, X. Shirley
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1038/ng.3581
Metadata
Show full item record
Citation
Li, B., T. Li, J. Pignon, B. Wang, J. Wang, S. Shukla, R. Dou, et al. 2016. “Landscape of tumor-infiltrating T cell repertoire of human cancers.” Nature genetics 48 (7): 725-732. doi:10.1038/ng.3581. http://dx.doi.org/10.1038/ng.3581.
Abstract
We developed a computational method to infer the complementarity determining region 3 (CDR3) sequences of tumor infiltrating T-cells in 9,142 RNA-seq samples across 29 cancer types. We identified over 600 thousand CDR3 sequences, including 15% with full-length. CDR3 sequence length distribution and amino acid conservation, as well as variable gene usage of infiltrating T-cells in many tumors, except brain and kidney cancers, resembled those in the peripheral blood of healthy donors. We observed a strong association between T-cell diversity and tumor mutation load, and predicted SPAG5 and TSSK6 as putative immunogenic cancer/testis antigens in multiple cancers. Finally, we identified 3 potential immunogenic somatic mutations based on their co-occurrence with CDR3 sequences. One of them, PRAMEF4 F300V, was predicted to bind strongly to both MHC-I and MHC-II, with matched HLA types in its carriers. Our analyses have the potential to simultaneously identify immunogenic neoantigens and the tumor-reactive T-cell clonotypes.
Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298896/pdf/
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:31731849

Collections
  • FAS Scholarly Articles [17584]
  • HMS Scholarly Articles [18123]
  • SPH Scholarly Articles [6392]

Contact administrator regarding this item (to report mistakes or request changes)

e: osc@harvard.edu

t: +1 (617) 495 4089

Creative Commons license‌Creative Commons Attribution 4.0 International License

Except where otherwise noted, this work is subject to a Creative Commons Attribution 4.0 International License, which allows anyone to share and adapt our material as long as proper attribution is given. For details and exceptions, see the Harvard Library Copyright Policy ©2022 Presidents and Fellows of Harvard College.

  • Follow us on Twitter
  • Contact
  • Harvard Library
  • Harvard University